...
首页> 外文期刊>Die Pharmazie >Antituberculosis agents IV: in vitro antimycobacterial activity and cytotoxicity of N-piperazinyl quinolone derivatives containing 2-thienyl and 2-furyl moiety.
【24h】

Antituberculosis agents IV: in vitro antimycobacterial activity and cytotoxicity of N-piperazinyl quinolone derivatives containing 2-thienyl and 2-furyl moiety.

机译:抗结核剂IV:含有2-噻吩基和2-呋喃基部分的N-哌嗪基喹诺酮衍生物的体外抗分枝杆菌活性和细胞毒性。

获取原文
获取原文并翻译 | 示例
           

摘要

A series of N-[2-(2-furyl)-2-oxoethyl], N-[2-(2-furyl)-2-oxyiminoethyl], N-[2-oxo-2-(2-thienyl)ethyl] and N-[2-oxyimino-2-(2-thienyl)ethyl] piperazinyl quinolones (1a-h; 2a-h) were evaluated for antituberculosis activity against M. tuberculosis H37Rv using the BACTEC 460 radiometric system and BACTEC 12B medium. Our results indicated that compounds 1a, 1e and 1g were efficient antimycobacterial agents showing MIC values ranging from 0.78 to 6.25 microg/ml. In general, ciprofloxacin derivatives were more active than norfloxacin derivatives and the oxime analogues were less active than corresponding ketones. Active compounds (1a, 1e and 1g) were also screened by serial dilution to assess toxicity to VERO cell line. The cytotoxicity of tested compounds indicated that compound 1a was the less toxic compound (IC50 > 62.5 microg/ml). This compound was tested for efficacy in vitro in TB-infected macrophage model (EC90 = 3.25 microg/ml).
机译:一系列的N- [2-(2-呋喃基)-2-氧代乙基],N- [2-(2-呋喃基)-2-氧亚氨基乙基],N- [2-氧代-2-(2-噻吩基)乙基使用BACTEC 460辐射系统和BACTEC 12B培养基评估了N- [2-氧亚氨基-2-(2-噻吩基)乙基]哌嗪基喹诺酮类药物(1a-h; 2a-h)对结核分枝杆菌H37Rv的抗结核活性。我们的结果表明,化合物1a,1e和1g是有效的抗分枝杆菌药,其MIC值为0.78至6.25 microg / ml。通常,环丙沙星衍生物的活性高于诺氟沙星衍生物,肟类似物的活性低于相应的酮。还通过系列稀释筛选了活性化合物(1a,1e和1g),以评估其对VERO细胞系的毒性。被测化合物的细胞毒性表明化合物1a是毒性较低的化合物(IC50> 62.5 microg / ml)。在结核病感染的巨噬细胞模型(EC90 = 3.25 microg / ml)中测试了该化合物的体外功效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号